Xiaolin Lü

3.1k citations
123 papers · 2.5k indexed · h-index 26

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Circular RNAs in diseases
    • RNA modifications and cancer
    • Epigenetics and DNA Methylation
    • Extracellular vesicles in disease

Papers in

    • Cancer-related molecular mechanisms research 14
    • MicroRNA in disease regulation 12
    • Folate and B Vitamins Research 17

Xiaolin Lü

120 papers receiving 2.4k citations

Peers

Xiaolin Lü
Comparison fields: 5 of 134
  • Cancer Research 989
  • Molecular Biology 1.5k
  • Rheumatology 176
  • Oncology 269
  • Renewable Energy, Sustainability and the Environment 153
Replace Robert M. Mader with:
Robert M. Mader Austria
Hongqian Guo China
Yubin Ge United States
Ulrich Bergmann Finland
Hitoshi Ishiguro Japan
Chunyang Jiang China
Javier Silva Spain
Thomas J. Lawton United States
Jianbo Wu China
Feng Cao China
Xiaolin Lü relative to Robert M. Mader Austria Robert M. Mader's profile →
Citations per field
00.5×2.9×
Robert M. Mader · 1×
Citations per year

Countries citing papers authored by Xiaolin Lü

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Lü more than expected).

Fields of papers citing papers by Xiaolin Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Lü. The network helps show where Xiaolin Lü may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaolin Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaolin Lü Line = papers co-authored together Xiaolin Lü links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2015237
2 2013156
3 2014115
4 201677
5 201575
6 201473
7 201770
8 201868
9 201067
10 201667
11 201564
12 201655
13 201453
14 201447
15 201647
16 202343
17 201443
18 201541
19 201440
20 201535

About Xiaolin Lü

Xiaolin Lü is a scholar working on Cancer Research, Rheumatology, Obstetrics and Gynecology, Complementary and alternative medicine and Molecular Biology, having authored 123 papers that have together received 2.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (18 papers), Folate and B Vitamins Research (17 papers), Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (12 papers), RNA modifications and cancer (10 papers), Circular RNAs in diseases (9 papers), Hedgehog Signaling Pathway Studies (7 papers) and Prenatal Screening and Diagnostics (7 papers). The work is most often cited by research in Cancer Research (989 citations), Molecular Biology (1.5k citations), Rheumatology (176 citations), Oncology (269 citations) and Renewable Energy, Sustainability and the Environment (153 citations). Xiaolin Lü has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Qizhan Liu, Yi Liu, Fei Luo, Le Shi, Xinlu Liu, Lu Lu, Wenchao Xu, Bairu Wang, Yue Xu and Fei Luo. Their work appears in journals such as Toxicology Letters, Birth Defects Research Part A Clinical and Molecular Teratology, Analytical Methods, Oncotarget and Toxicology and Applied Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026